My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 98

    1.

    Evaluation of the VP22 protein for enhancement of a DNA vaccine against anthrax.

    Perkins SD, Flick-Smith HC, Garmory HS, Essex-Lopresti AE, Stevenson FK, Phillpotts RJ.

    Genet Vaccines Ther. 2005 Apr 20;3(1):3.PMID: 15842732 [PubMed - as supplied by publisher]Related articlesFree article

    2.

    Oral administration of a Salmonella enterica-based vaccine expressing Bacillus anthracis protective antigen confers protection against aerosolized B. anthracis.

    Stokes MG, Titball RW, Neeson BN, Galen JE, Walker NJ, Stagg AJ, Jenner DC, Thwaite JE, Nataro JP, Baillie LW, Atkins HS.

    Infect Immun. 2007 Apr;75(4):1827-34. Epub 2006 Dec 4.PMID: 17145938 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Significant passive protective effect against anthrax by antibody to Bacillus anthracis inactivated spores that lack two virulence plasmids.

    Enkhtuya J, Kawamoto K, Kobayashi Y, Uchida I, Rana N, Makino S.

    Microbiology. 2006 Oct;152(Pt 10):3103-10.PMID: 17005989 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Killed but metabolically active Bacillus anthracis vaccines induce broad and protective immunity against anthrax.

    Skoble J, Beaber JW, Gao Y, Lovchik JA, Sower LE, Liu W, Luckett W, Peterson JW, Calendar R, Portnoy DA, Lyons CR, Dubensky TW Jr.

    Infect Immun. 2009 Apr;77(4):1649-63. Epub 2009 Jan 21.PMID: 19168734 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Enhancement of antibody responses to Bacillus anthracis protective antigen domain IV by use of calreticulin as a chimeric molecular adjuvant.

    Park YS, Lee JH, Hung CF, Wu TC, Kim TW.

    Infect Immun. 2008 May;76(5):1952-9. Epub 2008 Feb 19.PMID: 18285494 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Efficacy of a vaccine based on protective antigen and killed spores against experimental inhalational anthrax.

    Gauthier YP, Tournier JN, Paucod JC, Corre JP, Mock M, Goossens PL, Vidal DR.

    Infect Immun. 2009 Mar;77(3):1197-207. Epub 2008 Dec 29.PMID: 19114543 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    VP22 enhances antibody responses from DNA vaccines but not by intercellular spread.

    Perkins SD, Hartley MG, Lukaszewski RA, Phillpotts RJ, Stevenson FK, Bennett AM.

    Vaccine. 2005 Mar 14;23(16):1931-40.PMID: 15734065 [PubMed - indexed for MEDLINE]Related articles

    8.

    Induction of protective immunity to anthrax lethal toxin with a nonhuman primate adenovirus-based vaccine in the presence of preexisting anti-human adenovirus immunity.

    Hashimoto M, Boyer JL, Hackett NR, Wilson JM, Crystal RG.

    Infect Immun. 2005 Oct;73(10):6885-91.PMID: 16177368 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Detoxified lethal toxin as a potential mucosal vaccine against anthrax.

    Xu Q, Zeng M.

    Clin Vaccine Immunol. 2008 Apr;15(4):612-6. Epub 2008 Feb 6.PMID: 18256208 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Towards a human oral vaccine for anthrax: the utility of a Salmonella Typhi Ty21a-based prime-boost immunization strategy.

    Baillie LW, Rodriguez AL, Moore S, Atkins HS, Feng C, Nataro JP, Pasetti MF.

    Vaccine. 2008 Nov 11;26(48):6083-91. Epub 2008 Sep 19.PMID: 18805452 [PubMed - indexed for MEDLINE]Related articles

    11.

    Recombinant Bacillus anthracis spore proteins enhance protection of mice primed with suboptimal amounts of protective antigen.

    Cybulski RJ Jr, Sanz P, McDaniel D, Darnell S, Bull RL, O'Brien AD.

    Vaccine. 2008 Sep 8;26(38):4927-39. Epub 2008 Jul 25.PMID: 18657585 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Immunization against anthrax using Bacillus subtilis spores expressing the anthrax protective antigen.

    Duc le H, Hong HA, Atkins HS, Flick-Smith HC, Durrani Z, Rijpkema S, Titball RW, Cutting SM.

    Vaccine. 2007 Jan 4;25(2):346-55. Epub 2006 Aug 4.PMID: 17007969 [PubMed - indexed for MEDLINE]Related articles

    13.

    Multiagent vaccines vectored by Venezuelan equine encephalitis virus replicon elicits immune responses to Marburg virus and protection against anthrax and botulinum neurotoxin in mice.

    Lee JS, Groebner JL, Hadjipanayis AG, Negley DL, Schmaljohn AL, Welkos SL, Smith LA, Smith JF.

    Vaccine. 2006 Nov 17;24(47-48):6886-92. Epub 2006 Jun 21.PMID: 16828936 [PubMed - indexed for MEDLINE]Related articles

    14.

    [Immunogenicity of DNA vaccine expressing GP5 of porcine reproductive and respiratory syndrome virus fused with VP22 of bovine herpesvirus 1]

    Zhao W, Xiao SB, Fang LR, Jiang YB, Song YF, Yan L, Yu XL, Chen HC.

    Sheng Wu Gong Cheng Xue Bao. 2005 Sep;21(5):725-30. Chinese. PMID: 16285512 [PubMed - indexed for MEDLINE]Related articles

    15.

    Anthrax protective antigen delivered by Salmonella enterica serovar Typhi Ty21a protects mice from a lethal anthrax spore challenge.

    Osorio M, Wu Y, Singh S, Merkel TJ, Bhattacharyya S, Blake MS, Kopecko DJ.

    Infect Immun. 2009 Apr;77(4):1475-82. Epub 2009 Jan 29.PMID: 19179420 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Mucosal immunization with a novel nanoemulsion-based recombinant anthrax protective antigen vaccine protects against Bacillus anthracis spore challenge.

    Bielinska AU, Janczak KW, Landers JJ, Makidon P, Sower LE, Peterson JW, Baker JR Jr.

    Infect Immun. 2007 Aug;75(8):4020-9. Epub 2007 May 14.PMID: 17502384 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    DNA vaccination against anthrax in mice-combination of anti-spore and anti-toxin components.

    Hahn UK, Boehm R, Beyer W.

    Vaccine. 2006 May 22;24(21):4569-71. Epub 2005 Aug 24.PMID: 16157424 [PubMed - indexed for MEDLINE]Related articles

    18.

    Human monoclonal antibodies against anthrax lethal factor and protective antigen act independently to protect against Bacillus anthracis infection and enhance endogenous immunity to anthrax.

    Albrecht MT, Li H, Williamson ED, LeButt CS, Flick-Smith HC, Quinn CP, Westra H, Galloway D, Mateczun A, Goldman S, Groen H, Baillie LW.

    Infect Immun. 2007 Nov;75(11):5425-33. Epub 2007 Jul 23.PMID: 17646360 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    An intranasal vaccine targeting both the Bacillus anthracis toxin and bacterium provides protection against aerosol spore challenge in rabbits.

    Wimer-Mackin S, Hinchcliffe M, Petrie CR, Warwood SJ, Tino WT, Williams MS, Stenz JP, Cheff A, Richardson C.

    Vaccine. 2006 May 1;24(18):3953-63. Epub 2006 Feb 28.PMID: 16530302 [PubMed - indexed for MEDLINE]Related articles

    20.

    Immunogenicity of Bacillus anthracis protective antigen domains and efficacy of elicited antibody responses depend on host genetic background.

    Abboud N, Casadevall A.

    Clin Vaccine Immunol. 2008 Jul;15(7):1115-23. Epub 2008 May 14.PMID: 18480236 [PubMed - indexed for MEDLINE]Related articlesFree article

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination
    Write to the Help Desk